These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 12867408

  • 1. Infliximab in the treatment of refractory posterior uveitis.
    Joseph A, Raj D, Dua HS, Powell PT, Lanyon PC, Powell RJ.
    Ophthalmology; 2003 Jul; 110(7):1449-53. PubMed ID: 12867408
    [Abstract] [Full Text] [Related]

  • 2. Long-term treatment of refractory posterior uveitis with anti-TNFalpha (infliximab).
    Benitez-del-Castillo JM, Martinez-de-la-Casa JM, Pato-Cour E, Méndez-Fernández R, López-Abad C, Matilla M, Garcia-Sanchez J.
    Eye (Lond); 2005 Aug; 19(8):841-5. PubMed ID: 15389273
    [Abstract] [Full Text] [Related]

  • 3. Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study.
    Niccoli L, Nannini C, Benucci M, Chindamo D, Cassarà E, Salvarani C, Cimino L, Gini G, Lenzetti I, Cantini F.
    Rheumatology (Oxford); 2007 Jul; 46(7):1161-4. PubMed ID: 17478466
    [Abstract] [Full Text] [Related]

  • 4. Treatment of refractory posterior uveitis with infliximab: a 7-year follow-up study.
    Lopez-Gonzalez R, Loza E, Jover JA, Benitez Del Castillo JM, Mendez R, Hernandez-Garcia C, Pato E.
    Scand J Rheumatol; 2009 Jul; 38(1):58-62. PubMed ID: 18991187
    [Abstract] [Full Text] [Related]

  • 5. Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis.
    Murphy CC, Ayliffe WH, Booth A, Makanjuola D, Andrews PA, Jayne D.
    Ophthalmology; 2004 Feb; 111(2):352-6. PubMed ID: 15019389
    [Abstract] [Full Text] [Related]

  • 6. Tacrolimus (FK506) in the treatment of posterior uveitis refractory to cyclosporine.
    Sloper CM, Powell RJ, Dua HS.
    Ophthalmology; 1999 Apr; 106(4):723-8. PubMed ID: 10201592
    [Abstract] [Full Text] [Related]

  • 7. Retrospective case review of pediatric patients with uveitis treated with infliximab.
    Rajaraman RT, Kimura Y, Li S, Haines K, Chu DS.
    Ophthalmology; 2006 Feb; 113(2):308-14. PubMed ID: 16406545
    [Abstract] [Full Text] [Related]

  • 8. Initial evaluation of subcutaneous daclizumab treatments for noninfectious uveitis: a multicenter noncomparative interventional case series.
    Nussenblatt RB, Peterson JS, Foster CS, Rao NA, See RF, Letko E, Buggage RR.
    Ophthalmology; 2005 May; 112(5):764-70. PubMed ID: 15878055
    [Abstract] [Full Text] [Related]

  • 9. [The treatment of recurrent uveitis with TNF-alpha inhibitors].
    Falappone PC, Iannone F, Scioscia C, Grattagliano V, Covelli M, Lapadula G.
    Reumatismo; 2004 May; 56(3):185-9. PubMed ID: 15470524
    [Abstract] [Full Text] [Related]

  • 10. Intravitreal infliximab for sight-threatening relapsing uveitis in Behçet disease: a pilot study in 15 patients.
    Markomichelakis N, Delicha E, Masselos S, Sfikakis PP.
    Am J Ophthalmol; 2012 Sep; 154(3):534-541.e1. PubMed ID: 22789563
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial.
    Tugal-Tutkun I, Mudun A, Urgancioglu M, Kamali S, Kasapoglu E, Inanc M, Gül A.
    Arthritis Rheum; 2005 Aug; 52(8):2478-84. PubMed ID: 16052571
    [Abstract] [Full Text] [Related]

  • 12. Anti-TNF-alpha therapy in seven patients with Behcet's uveitis: advantages and controversial aspects.
    Tognon S, Graziani G, Marcolongo R.
    Ann N Y Acad Sci; 2007 Sep; 1110():474-84. PubMed ID: 17911463
    [Abstract] [Full Text] [Related]

  • 13. Loss of efficacy during long-term infliximab therapy for sight-threatening childhood uveitis.
    Simonini G, Zannin ME, Caputo R, Falcini F, de Martino M, Zulian F, Cimaz R.
    Rheumatology (Oxford); 2008 Oct; 47(10):1510-4. PubMed ID: 18676502
    [Abstract] [Full Text] [Related]

  • 14. Favorable response to high-dose infliximab for refractory childhood uveitis.
    Kahn P, Weiss M, Imundo LF, Levy DM.
    Ophthalmology; 2006 May; 113(5):860-4.e2. PubMed ID: 16545455
    [Abstract] [Full Text] [Related]

  • 15. Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation.
    Galor A, Perez VL, Hammel JP, Lowder CY.
    Ophthalmology; 2006 Dec; 113(12):2317-23. PubMed ID: 16996615
    [Abstract] [Full Text] [Related]

  • 16. Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis.
    Ohno S, Nakamura S, Hori S, Shimakawa M, Kawashima H, Mochizuki M, Sugita S, Ueno S, Yoshizaki K, Inaba G.
    J Rheumatol; 2004 Jul; 31(7):1362-8. PubMed ID: 15229958
    [Abstract] [Full Text] [Related]

  • 17. A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes.
    Suhler EB, Smith JR, Wertheim MS, Lauer AK, Kurz DE, Pickard TD, Rosenbaum JT.
    Arch Ophthalmol; 2005 Jul; 123(7):903-12. PubMed ID: 16009830
    [Abstract] [Full Text] [Related]

  • 18. Effects of infliximab in the treatment of refractory posterior uveitis of Behçet's disease after withdrawal of infusions.
    Adán A, Hernandez V, Ortiz S, Molina JJ, Pelegrin L, Espinosa G, Sanmartí R.
    Int Ophthalmol; 2010 Oct; 30(5):577-81. PubMed ID: 20490893
    [Abstract] [Full Text] [Related]

  • 19. Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis.
    Jaffe GJ, McCallum RM, Branchaud B, Skalak C, Butuner Z, Ashton P.
    Ophthalmology; 2005 Jul; 112(7):1192-8. PubMed ID: 15921758
    [Abstract] [Full Text] [Related]

  • 20. Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Behçet disease.
    Tabbara KF, Al-Hemidan AI.
    Am J Ophthalmol; 2008 Dec; 146(6):845-50.e1. PubMed ID: 18929351
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.